YCM
PBMWW

Yakira Capital Management’s Psyence Biomedical Warrant PBMWW Stock Holding History

Yakira Capital Management’s Portfolio PBMWW Stock Details PBMWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-76,843
Closed -$1.56K – 233
2025
Q2 		$1.56K Hold
76,843
– – ﹤0.01% 189
2025
Q1 		$1.3K Hold
76,843
– – ﹤0.01% 197
2024
Q4 		$1.11K Hold
76,843
– – ﹤0.01% 228
2024
Q3 		$968 Hold
76,843
– – ﹤0.01% 253
2024
Q2 		$807 Hold
76,843
– – ﹤0.01% 269
2024
Q1 		$5.38K Buy
+76,843
New +$4.79K ﹤0.01% 239

Other funds holding PBMWW

HCI
Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Yakira Capital Management's PBMWW Position: Q3 2025 in Review

Yakira Capital Management sold out of Psyence Biomedical Warrant (PBMWW) in Q3 2025, closing a stake of 76,843 shares — an estimated $1.56K sold.

Yakira Capital Management first reported a position in PBMWW in Q1 2024 and held it in 6 quarters. The position peaked at $5.38K in Q1 2024. 23 funds tracked by Wall St. Rank hold PBMWW as of Q3 2025.

  • Yakira Capital Management reported no remaining Psyence Biomedical Warrant position as of Q3 2025 after selling out during the quarter.
  • Yakira Capital Management sold 76,843 Psyence Biomedical Warrant shares in Q3 2025, an estimated $1.56K.
  • Yakira Capital Management first reported a position in Psyence Biomedical Warrant in Q1 2024 and held it in 6 quarters.
  • Yakira Capital Management's Psyence Biomedical Warrant position peaked at $5.38K in Q1 2024.
  • 23 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q3 2025.

Based on Yakira Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.